PONIARD PHARMACEUTICALS, INC. CHANGE OF CONTROL AGREEMENT (VP)Change of Control Agreement • June 23rd, 2006 • Poniard Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledJune 23rd, 2006 Company IndustryThis Change of Control Agreement (VP) (this “Agreement”), dated as of July 1, 2006, is entered into by and between PONIARD PHARMACEUTICALS, INC. (formerly NeoRx Corporation), a Washington corporation (as supplemented by Section 13, the “Company”), and Cheni Kwok (the “Executive”).
PONIARD PHARMACEUTICALS, INC. KEY EXECUTIVE SEVERANCE AGREEMENT (VP)Severance Agreement • June 23rd, 2006 • Poniard Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledJune 23rd, 2006 Company IndustryThis Key Executive Severance Agreement (VP) (this “Agreement”), dated as of July 1, 2006, is entered into by and between PONIARD PHARMACEUTICALS, INC. (formerly NeoRx Corporation), a Washington corporation (as supplemented by Section 10, the “Company”), and Cheni Kwok (the “Executive”).
PONIARD PHARMACEUTICALS, INC. CHANGE OF CONTROL AGREEMENT (VP)Control Agreement • June 23rd, 2006 • Poniard Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledJune 23rd, 2006 Company IndustryThis Change of Control Agreement (VP) (this “Agreement”), dated as of June 23, 2006, is entered into by and between PONIARD PHARMACEUTICALS, INC., a Washington corporation (as supplemented by Section 13, the “Company”), and Caroline M. Loewy (the “Executive”).